Cell cycle agents and cyclophosphamide in the treatment of diffuse histiocytic lymphoma
- 1 October 1978
- journal article
- research article
- Published by Elsevier
- Vol. 14 (10) , 1051-1055
- https://doi.org/10.1016/0014-2964(78)90060-9
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Drugs Five Years Later: MethotrexateAnnals of Internal Medicine, 1977
- Bleomycin, Adriamycin, Cyclophosphamide, Vincristine, and Prednisone (BACOP) Combination Chemotherapy in the Treatment of Advanced Diffuse Histiocytic LymphomaAnnals of Internal Medicine, 1976
- Multiple agent chemotherapy for advanced histiocytic lymphomaPublished by Elsevier ,1976
- Potential for Prolonged Disease-free Survival Following Combination Chemotherapy of Non-Hodgkin’s LymphomaBlood, 1974
- Combination chemotherapy: The antagonism of methotrexate and cytosine arabinosidePublished by Elsevier ,1973
- Advanced Lymphosarcoma: Intensive Cyclical Combination Chemotherapy with Cyclophosphamide, Vincristine, and PrednisoneAnnals of Internal Medicine, 1972
- Synchronization and recruitment in acute leukemiaJournal of Clinical Investigation, 1971
- Combination Chemotherapy in Lymphosarcoma and Reticulum Cell SarcomaBlood, 1969
- Clinical studies of dichloromethotrexate (NSC 29630)Clinical Pharmacology & Therapeutics, 1965
- Toxicity and Antitumor Effect Of Divided Doses of MethotrexateArchives of internal medicine (1960), 1965